Department of Pediatrics, Rijnstate Hospital Arnhem, Wagnerlaan 55, 6815 AD, Arnhem, The Netherlands.
Department of Pediatrics, Gastroenterology, Hepatology and Nutrition Unit, University Medical Centre Maribor, Maribor, Slovenia.
Eur J Pediatr. 2022 Mar;181(3):1213-1220. doi: 10.1007/s00431-021-04318-2. Epub 2021 Nov 24.
Adequate follow-up in celiac disease is important to improve dietary compliance and treat disease-related symptoms and possible complications. However, data on the follow-up of celiac children is scarce. We aimed to assess current pediatric celiac follow-up practices across Europe. Pediatricians and pediatric gastroenterologists from 35 countries in Europe, Israel, Turkey, and Russia completed an anonymous survey which comprised a 52-item questionnaire developed by the ESPGHAN Special Interest Group on Celiac Disease. A total of 911 physicians, the majority of whom exclusively worked in pediatric care (83%) and academic institutions (60%), completed the questionnaire. Mean age and mean experience with celiac care were 48.7 years (± 10.6) and 15.7 years (± 9.9), respectively. The vast majority (≥ 92%) always assessed anthropometry, dietary adherence, and tissue-transglutaminase IgA-antibodies at every visit, with the first visit being between 3 and 6 months after diagnosis. Other parameters (% always tested) were as follows: complete blood count (60%), iron status (48%), liver enzymes (42%), thyroid function (38%), and vitamin D (26%). Quality of life was never assessed by 35% of the responding physicians. Transition to adult care was mostly completed via a written transition report (37%) or no formal transition at all (27%).Conclusions: Follow-up of celiac children and adolescents in Europe may be improved, especially regarding a more rational use of (laboratory) tests, dietary and QoL assessment, and transition to adult care. Evidence-based advice from international scientific societies is needed. What is Known: • Follow-up in celiac disease is important to treat disease-related symptoms, improve dietary compliance, and prevent possible complications. • There is a lack of consensus about the appropriate follow-up. What is New: • Almost all European physicians assess anthropometry, tissue-transglutaminase IgA-antibodies, and dietary adherence at every visit, but there are large variations in other follow-up aspects. • Follow-up could be improved by a more rational use of (laboratory) tests, increased intention to dietary compliance, and quality of life together with transition programs to adult care.
在乳糜泻中进行充分的随访对于改善饮食依从性、治疗与疾病相关的症状和可能的并发症非常重要。然而,关于乳糜泻患儿随访的数据却很少。我们旨在评估欧洲各地儿科乳糜泻的随访实践。来自欧洲 35 个国家、以色列、土耳其和俄罗斯的儿科医生和儿科胃肠病学家完成了一项匿名调查,该调查由 ESPGHAN 乳糜泻特别兴趣小组制定了一个包含 52 个项目的问卷。共有 911 名医生完成了问卷,他们中的大多数人(83%)专门从事儿科护理,(60%)在学术机构工作。平均年龄和从事乳糜泻护理的平均经验分别为 48.7±10.6 岁和 15.7±9.9 年。绝大多数(≥92%)医生总是在每次就诊时评估人体测量学、饮食依从性和组织转谷氨酰胺酶 IgA 抗体,首次就诊时间在诊断后 3-6 个月之间。其他经常测试的参数(%)如下:全血细胞计数(60%)、铁状态(48%)、肝酶(42%)、甲状腺功能(38%)和维生素 D(26%)。35%的医生从不评估生活质量。向成人护理的过渡主要通过书面过渡报告(37%)或根本没有正式过渡(27%)完成。结论:欧洲儿童和青少年乳糜泻的随访可能需要改进,特别是在更合理地使用(实验室)检查、饮食和生活质量评估以及向成人护理过渡方面。需要来自国际科学协会的循证建议。已知:• 乳糜泻的随访对于治疗与疾病相关的症状、改善饮食依从性和预防可能的并发症非常重要。• 关于适当的随访尚无共识。新内容:• 几乎所有的欧洲医生在每次就诊时都会评估人体测量学、组织转谷氨酰胺酶 IgA 抗体和饮食依从性,但在其他随访方面存在很大差异。• 通过更合理地使用(实验室)检查、提高对饮食依从性的意愿以及生活质量,并结合向成人护理的过渡计划,随访可以得到改善。